Amicus Therapeutics, Inc. (FOLD)
USD 6.67
(-0.15%)
USD 6.67
(-0.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 445.05 Million USD | -1.56% |
| 2022 | 452.12 Million USD | 2.72% |
| 2021 | 440.12 Million USD | -0.36% |
| 2020 | 441.73 Million USD | 110.12% |
| 2019 | 210.22 Million USD | -34.66% |
| 2018 | 321.74 Million USD | 95.62% |
| 2017 | 164.47 Million USD | 6.48% |
| 2016 | 154.46 Million USD | 271.3% |
| 2015 | 41.6 Million USD | 189.9% |
| 2014 | 14.35 Million USD | -0.85% |
| 2013 | 14.47 Million USD | 1976.47% |
| 2012 | 697 Thousand USD | -33.24% |
| 2011 | 1.04 Million USD | -55.33% |
| 2010 | 2.33 Million USD | -40.11% |
| 2009 | 3.9 Million USD | 226.8% |
| 2008 | 1.19 Million USD | -56.12% |
| 2007 | 2.72 Million USD | -23.64% |
| 2006 | 3.56 Million USD | 251.56% |
| 2005 | 1.01 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 444.05 Million USD | -0.1% |
| 2024 Q1 | 444.49 Million USD | -0.13% |
| 2023 Q4 | 445.05 Million USD | -2.03% |
| 2023 Q2 | 452.16 Million USD | 0.03% |
| 2023 Q1 | 452.01 Million USD | -0.02% |
| 2023 FY | 445.05 Million USD | -1.56% |
| 2023 Q3 | 454.29 Million USD | 0.47% |
| 2022 Q1 | 447.7 Million USD | 1.72% |
| 2022 Q2 | 451.03 Million USD | 0.74% |
| 2022 Q3 | 450.86 Million USD | -0.04% |
| 2022 Q4 | 452.12 Million USD | 0.28% |
| 2022 FY | 452.12 Million USD | 2.72% |
| 2021 FY | 440.12 Million USD | -0.36% |
| 2021 Q2 | 441.74 Million USD | 0.17% |
| 2021 Q3 | 439.38 Million USD | -0.53% |
| 2021 Q1 | 440.98 Million USD | -0.17% |
| 2021 Q4 | 440.12 Million USD | 0.17% |
| 2020 Q3 | 440.57 Million USD | 117.87% |
| 2020 Q1 | 209.76 Million USD | -0.22% |
| 2020 Q2 | 202.21 Million USD | -3.6% |
| 2020 FY | 441.73 Million USD | 110.12% |
| 2020 Q4 | 441.73 Million USD | 0.26% |
| 2019 Q4 | 210.22 Million USD | 2.4% |
| 2019 FY | 210.22 Million USD | -34.66% |
| 2019 Q1 | 207.44 Million USD | -35.53% |
| 2019 Q2 | 188 Million USD | -9.37% |
| 2019 Q3 | 205.3 Million USD | 9.2% |
| 2018 Q1 | 166.76 Million USD | 1.39% |
| 2018 Q3 | 318.8 Million USD | 88.15% |
| 2018 Q4 | 321.74 Million USD | 0.92% |
| 2018 FY | 321.74 Million USD | 95.62% |
| 2018 Q2 | 169.44 Million USD | 1.6% |
| 2017 Q2 | 159.17 Million USD | 1.47% |
| 2017 FY | 164.47 Million USD | 6.48% |
| 2017 Q4 | 164.47 Million USD | 1.76% |
| 2017 Q3 | 161.63 Million USD | 1.55% |
| 2017 Q1 | 156.85 Million USD | 1.36% |
| 2016 Q1 | 38.5 Million USD | -7.43% |
| 2016 FY | 154.46 Million USD | 271.3% |
| 2016 Q4 | 154.74 Million USD | 134.38% |
| 2016 Q3 | 66.02 Million USD | 1.12% |
| 2016 Q2 | 65.29 Million USD | 69.56% |
| 2015 Q3 | 50 Million USD | 0.0% |
| 2015 FY | 41.6 Million USD | 189.9% |
| 2015 Q1 | 14.39 Million USD | 0.33% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q4 | 41.6 Million USD | -16.8% |
| 2014 Q1 | 14.41 Million USD | -0.4% |
| 2014 FY | 14.35 Million USD | -0.85% |
| 2014 Q2 | 14.35 Million USD | -0.4% |
| 2014 Q3 | 14.3 Million USD | -0.38% |
| 2014 Q4 | 14.35 Million USD | 0.34% |
| 2013 Q4 | 14.47 Million USD | 3536.43% |
| 2013 Q2 | 498 Thousand USD | -16.58% |
| 2013 Q1 | 597 Thousand USD | -14.35% |
| 2013 FY | 14.47 Million USD | 1976.47% |
| 2013 Q3 | 398 Thousand USD | -20.08% |
| 2012 Q4 | 697 Thousand USD | -22.56% |
| 2012 Q3 | 900 Thousand USD | -31.51% |
| 2012 Q1 | 1.72 Million USD | 65.33% |
| 2012 FY | 697 Thousand USD | -33.24% |
| 2012 Q2 | 1.31 Million USD | -23.87% |
| 2011 Q4 | 1.04 Million USD | -23.07% |
| 2011 Q1 | 1.98 Million USD | -15.1% |
| 2011 FY | 1.04 Million USD | -55.33% |
| 2011 Q3 | 1.35 Million USD | -18.79% |
| 2011 Q2 | 1.67 Million USD | -15.78% |
| 2010 Q3 | 2.69 Million USD | -12.04% |
| 2010 FY | 2.33 Million USD | -40.11% |
| 2010 Q4 | 2.33 Million USD | -13.32% |
| 2010 Q2 | 3.06 Million USD | -12.1% |
| 2010 Q1 | 3.48 Million USD | -10.64% |
| 2009 Q3 | 4.24 Million USD | 53.99% |
| 2009 Q2 | 2.75 Million USD | 200.0% |
| 2009 Q4 | 3.9 Million USD | -7.99% |
| 2009 FY | 3.9 Million USD | 226.8% |
| 2009 Q1 | 918 Thousand USD | -23.12% |
| 2008 Q3 | 1.57 Million USD | -19.46% |
| 2008 Q1 | 2.33 Million USD | -14.08% |
| 2008 FY | 1.19 Million USD | -56.12% |
| 2008 Q4 | 1.19 Million USD | -24.09% |
| 2008 Q2 | 1.95 Million USD | -16.47% |
| 2007 Q3 | 3.09 Million USD | -10.5% |
| 2007 Q1 | 3.24 Million USD | -8.83% |
| 2007 Q2 | 3.45 Million USD | 6.4% |
| 2007 Q4 | 2.72 Million USD | -12.06% |
| 2007 FY | 2.72 Million USD | -23.64% |
| 2006 Q4 | 3.56 Million USD | 0.0% |
| 2006 FY | 3.56 Million USD | 251.56% |
| 2005 Q4 | 1.01 Million USD | 0.0% |
| 2005 FY | 1.01 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -313321.831% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5712.145% |
| XOMA Corporation | 124.45 Million USD | -257.621% |
| Mesoblast Limited | 118.92 Million USD | -274.241% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -94.187% |
| Aptorum Group Limited | 3.36 Million USD | -13136.361% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -34155.967% |
| HilleVax, Inc. | 51.19 Million USD | -769.375% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1677.25% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2031.077% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1323.369% |
| Dyadic International, Inc. | 136.92 Thousand USD | -324929.03% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -281582.911% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -15396.483% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -8058.735% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -207871.495% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -8037.85% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -93.983% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3482.252% |
| IGM Biosciences, Inc. | 40.5 Million USD | -998.748% |
| Opthea Limited | 200.62 Million USD | -121.832% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -759.602% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -8141.833% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4435.402% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -7119.124% |
| NextCure, Inc. | 6.6 Million USD | -6638.213% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -71452.549% |
| Ovid Therapeutics Inc. | 46 Million USD | -867.483% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1995.48% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1372.925% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -616.97% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1081.593% |
| Apollomics, Inc. | 4.66 Million USD | -9448.573% |
| PureTech Health plc | 25.51 Million USD | -1644.508% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -139855.66% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3329.863% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -425.615% |
| ChromaDex Corporation | 3.27 Million USD | -13481.294% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -327.194% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1068.011% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -324.776% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -329.859% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -338.983% |
| Fortress Biotech, Inc. | 88.59 Million USD | -402.369% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -604.575% |
| Celcuity Inc. | 37.44 Million USD | -1088.527% |
| ContextLogic Inc. | 6 Million USD | -7317.65% |
| GH Research PLC | 343 Thousand USD | -129654.81% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6685.47% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1202762.162% |
| ImmuCell Corporation | 11.96 Million USD | -3618.337% |
| Amarin Corporation plc | 8.73 Million USD | -4993.957% |
| TG Therapeutics, Inc. | 110.79 Million USD | -301.696% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -663.643% |
| Acelyrin, Inc. | 1.19 Million USD | -37174.623% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1474.928% |
| Novavax, Inc. | 280.63 Million USD | -58.59% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -220.117% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 92.322% |
| AnaptysBio, Inc. | 17.81 Million USD | -2398.366% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -8146.415% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3249.834% |
| AbCellera Biologics Inc. | 77.38 Million USD | -475.16% |
| CorMedix Inc. | 667.63 Thousand USD | -66562.323% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3962.611% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 83.534% |
| Aptose Biosciences Inc. | 1 Million USD | -43973.713% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -5141524.307% |
| Soligenix, Inc. | 3.49 Million USD | -12635.763% |
| Century Therapeutics, Inc. | 48.17 Million USD | -823.915% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -286.433% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -98676.663% |
| Kura Oncology, Inc. | 17.2 Million USD | -2487.552% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -6344.526% |
| Ardelyx, Inc. | 55.98 Million USD | -695.004% |
| Ainos, Inc. | 5.96 Million USD | -7362.98% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -381.494% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -20600.419% |
| Prothena Corporation plc | 11.83 Million USD | -3660.532% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -3084.908% |
| Autolus Therapeutics plc | 52.96 Million USD | -740.257% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1663.658% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -963.64% |
| Celularity Inc. | 65.41 Million USD | -580.342% |
| Rallybio Corporation | 392 Thousand USD | -113435.459% |
| GRI Bio, Inc. | 14 Thousand USD | -3178892.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -31.565% |
| INmune Bio, Inc. | 10.43 Million USD | -4164.243% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -147.767% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7434.358% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -544781.244% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -53726.236% |
| Humacyte, Inc. | 58.1 Million USD | -665.943% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -669.04% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 7.442% |
| Immunocore Holdings plc | 84.03 Million USD | -429.63% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -23918.295% |
| Verastem, Inc. | 41.55 Million USD | -970.96% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3813.639% |
| Histogen Inc. | 4.62 Million USD | -9529.143% |
| Surrozen, Inc. | 3.37 Million USD | -13071.323% |
| Blueprint Medicines Corporation | 774.12 Million USD | 42.508% |
| Organovo Holdings, Inc. | 1.39 Million USD | -31826.758% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -17745.188% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -767243.103% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -426.149% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -212826.514% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -8769.251% |
| Summit Therapeutics Inc. | 106.09 Million USD | -319.475% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -303.287% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -274091.243% |
| Turnstone Biologics Corp. | 3.21 Million USD | -13747.511% |
| Pulmatrix, Inc. | 8.75 Million USD | -4982.903% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -180085.83% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -355.97% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -3113.422% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -285.847% |
| Cytokinetics, Incorporated | 755.77 Million USD | 41.112% |
| Exelixis, Inc. | 189.94 Million USD | -134.311% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1353.776% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -301.214% |
| Evogene Ltd. | 1.13 Million USD | -39008.875% |
| Replimune Group, Inc. | 75.86 Million USD | -486.615% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1765.949% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -806677.848% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -15874.838% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -553952.136% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -910599.816% |
| BioLineRx Ltd. | 11.59 Million USD | -3739.695% |
| Avid Bioservices, Inc. | 207.83 Million USD | -114.142% |
| Insmed Incorporated | 1.2 Billion USD | 63.035% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -20893.349% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -872.318% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -684606.154% |
| MediWound Ltd. | 6.71 Million USD | -6531.784% |
| MiMedx Group, Inc. | 48.09 Million USD | -825.298% |
| OmniAb, Inc. | 25.56 Million USD | -1641.164% |
| Alector, Inc. | 38.91 Million USD | -1043.581% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -108.034% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -7.236% |
| Mereo BioPharma Group plc | 5.95 Million USD | -7377.47% |
| Zai Lab Limited | 15.15 Million USD | -2837.489% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 6.976% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -27120.734% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2175.702% |
| Immunic, Inc. | 1.33 Million USD | -33262.744% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1523.414% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1302.556% |
| Veracyte, Inc. | 12.63 Million USD | -3423.824% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 30.984% |
| FibroGen, Inc. | 170.45 Million USD | -161.101% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4800.991% |
| Allakos Inc. | 41.46 Million USD | -973.337% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1005.215% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -4012.919% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -294641.06% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -27141.628% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -218161.398% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -10404.107% |
| Precigen, Inc. | 7.09 Million USD | -6171.086% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 73.477% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5982.534% |
| Incyte Corporation | 38.28 Million USD | -1062.429% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -147900.758% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -931.017% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3895.861% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -15874.838% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -86.504% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1608.939% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -127424.069% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1555.664% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -887.418% |
| Agenus Inc. | 350.24 Million USD | -27.07% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -416267.14% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -31264.271% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -883.86% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -930.969% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -822.804% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -271332.056% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 47.561% |
| UroGen Pharma Ltd. | 100.21 Million USD | -344.109% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -43219.045% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -143.536% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -3135443.187% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -145820.984% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -113434.88% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6411.47% |
| Chimerix, Inc. | 2.14 Million USD | -20658.349% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -45640.904% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1151.739% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -257646.724% |
| Pluri Inc. | 29.61 Million USD | -1402.968% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2928.642% |
| MeiraGTx Holdings plc | 89.26 Million USD | -398.587% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2084485.48% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -9025.672% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -619.95% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -327.547% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -6334.278% |
| NLS Pharmaceutics AG | 1.63 Million USD | -27141.628% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1310.736% |
| Nutriband Inc. | 241.28 Thousand USD | -184353.654% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -8040.827% |
| Vor Biopharma Inc. | 35.66 Million USD | -1148.062% |
| Roivant Sciences Ltd. | 499.74 Million USD | 10.943% |
| ProKidney Corp. | 4.41 Million USD | -9985.18% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -36201.713% |
| Daré Bioscience, Inc. | 5.31 Million USD | -8268.689% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 74.42% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -78671.504% |
| Bicycle Therapeutics plc | 44.95 Million USD | -889.988% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1043.523% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -519.799% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -406.071% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2601.256% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -18058.292% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -65834.667% |
| MediciNova, Inc. | 215.92 Thousand USD | -206016.447% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -17738.036% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -35193.348% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -38906.047% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -138.801% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4222.64% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -696.754% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -12297.187% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4758.192% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2933.597% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3530.764% |
| bluebird bio, Inc. | 330.32 Million USD | -34.733% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3458.764% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -27293.067% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 60.749% |
| BioAtla, Inc. | 2.46 Million USD | -17991.829% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -367.887% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7924.865% |
| DBV Technologies S.A. | 14.38 Million USD | -2994.771% |
| Fortress Biotech, Inc. | 88.59 Million USD | -402.369% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4417.448% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2250.705% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2848.387% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2014.495% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -136215.021% |
| Galecto, Inc. | 249 Thousand USD | -178638.554% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -27175.368% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 70.315% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -319.614% |
| Entera Bio Ltd. | 390 Thousand USD | -114017.692% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -9.95% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -7069.12% |
| Xencor, Inc. | 83.43 Million USD | -433.426% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -26281.683% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -9556.303% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -36254.317% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4632.656% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -271332.056% |
| Portage Biotech Inc. | 47 Thousand USD | -946834.043% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -35193.348% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -18313.695% |
| OncoCyte Corporation | 2.86 Million USD | -15412.687% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -295514.198% |
| Purple Biotech Ltd. | 351 Thousand USD | -126697.436% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -13988.604% |
| Onconetix, Inc. | 9.88 Million USD | -4402.016% |
| MacroGenics, Inc. | 33.97 Million USD | -1210.115% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -21780.984% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -8408.106% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -3164.571% |
| Aditxt, Inc. | 18.21 Million USD | -2342.965% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1564.519% |
| Curis, Inc. | 2.79 Million USD | -15829.098% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -20731.717% |
| Adagene Inc. | 22.3 Million USD | -1895.166% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2560.086% |
| BeiGene, Ltd. | 930.18 Million USD | 52.154% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -111.791% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -54954.169% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 27.155% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -585503.947% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -17688.129% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -442.644% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -116.136% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -9483.527% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 83.41% |
| ADMA Biologics, Inc. | 141.41 Million USD | -214.712% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -634.675% |
| Clene Inc. | 32.16 Million USD | -1283.847% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -17408.222% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2260.68% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -20176.036% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -778.313% |
| Adicet Bio, Inc. | 20.92 Million USD | -2027.026% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -130.371% |
| Absci Corporation | 15.95 Million USD | -2689.114% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2808.312% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2093.165% |
| Surrozen, Inc. | 3.37 Million USD | -13071.323% |
| Generation Bio Co. | 97.89 Million USD | -354.634% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -135176.292% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1519.28% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1659.266% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1713.459% |
| Invivyd, Inc. | 2.16 Million USD | -20456.998% |
| Cingulate Inc. | 3.13 Million USD | -14096.011% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -732.415% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -12630237.739% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -88751.334% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -7929.208% |
| Jaguar Health, Inc. | 35.86 Million USD | -1141.102% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -706342.857% |
| 2seventy bio, Inc. | 256.67 Million USD | -73.395% |
| Clearside Biomedical, Inc. | 43 Million USD | -934.997% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -73707.463% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -678.007% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7830.271% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -92380.753% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1474.204% |
| Innoviva, Inc. | 449.07 Million USD | 0.895% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2101.192% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -552.292% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2488.004% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -257.362% |
| Evaxion Biotech A/S | 10.86 Million USD | -3994.5% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -433.714% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -494.149% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6751.278% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1085409.756% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1548.977% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -95611.613% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -1522.586% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4257.77% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -12412.201% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -28521.158% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -35222.143% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2981.273% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -49023.51% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -760.383% |
| ImmunityBio, Inc. | 883.67 Million USD | 49.636% |
| Korro Bio, Inc. | 33.2 Million USD | -1240.257% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -527.056% |
| Kineta, Inc. | 1.31 Million USD | -33693.394% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -189714.092% |
| BioVie Inc. | 6.11 Million USD | -7182.383% |
| Codexis, Inc. | 22.36 Million USD | -1890.069% |
| Celularity Inc. | 65.41 Million USD | -580.342% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -116103.394% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -198321.311% |
| Kodiak Sciences Inc. | 181.63 Million USD | -145.033% |
| Cibus, Inc. | 24.62 Million USD | -1707.64% |
| Annexon, Inc. | 31.35 Million USD | -1319.42% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -18903.373% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 69.381% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -493.127% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -11302.998% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -2663.01% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -299.192% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -866.7% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1285.7% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -45083.655% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3784.603% |
| Alkermes plc | 290.73 Million USD | -53.083% |
| Arcellx, Inc. | 97.62 Million USD | -355.886% |
| Moolec Science SA | 2.64 Million USD | -16724.589% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -20610.051% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -6949.881% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1578.644% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -14247.485% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -18428.684% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -25581.42% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -665.943% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1462.323% |
| Geron Corporation | 85.89 Million USD | -418.119% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -877.937% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 92.746% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -386054.927% |
| Notable Labs, Ltd. | 2.04 Million USD | -21620.791% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1215.575% |
| Structure Therapeutics Inc. | 5.45 Million USD | -8061.726% |
| IN8bio, Inc. | 4.89 Million USD | -8995.831% |
| 89bio, Inc. | 27.1 Million USD | -1541.799% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -111164.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -728.664% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -17568.083% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -33163.004% |
| Liquidia Corporation | 3.5 Million USD | -12605.081% |
| Mustang Bio, Inc. | 2.49 Million USD | -17716.613% |
| Immunovant, Inc. | 138 Thousand USD | -322406.522% |
| Vericel Corporation | 88.14 Million USD | -404.928% |
| Quantum-Si incorporated | 15.3 Million USD | -2808.312% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -5003.302% |
| XOMA Corporation | 124.45 Million USD | -257.621% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -162330.292% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -544781.244% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3252.358% |
| Vaxcyte, Inc. | 29.22 Million USD | -1422.923% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3981.987% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -219140.887% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2054.102% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -26824.319% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -35222.143% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -110336.476% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -43025.872% |
| PepGen Inc. | 20.1 Million USD | -2113.783% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -77436.411% |
| United Therapeutics Corporation | 700 Million USD | 36.42% |
| Solid Biosciences Inc. | 26.26 Million USD | -1594.495% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -45083.655% |
| Immuneering Corporation | 4.46 Million USD | -9872.285% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -440552.475% |
| Belite Bio, Inc | 886 Thousand USD | -50132.393% |
| Pharming Group N.V. | 171.54 Million USD | -159.442% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -85.737% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1986.442% |
| uniQure N.V. | 138.4 Million USD | -221.554% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2544.439% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -421.006% |
| Altimmune, Inc. | 671 Thousand USD | -66227.72% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3252.358% |
| Peak Bio, Inc. | 10.72 Million USD | -4050.97% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4800.991% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -25375.615% |
| Benitec Biopharma Inc. | 284 Thousand USD | -156610.915% |
| Zura Bio Limited | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -153557.779% |
| Compugen Ltd. | 1.35 Million USD | -32842.931% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -211340.503% |
| argenx SE | 20 Million USD | -2125.295% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -940.684% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -426.354% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2134.12% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -279.766% |
| PolyPid Ltd. | 11.77 Million USD | -3678.411% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -386.627% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -10544.798% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -75978.462% |
| Instil Bio, Inc. | 86.05 Million USD | -417.186% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1376.786% |
| Immunome, Inc. | 1.65 Million USD | -26873.273% |
| Verona Pharma plc | 51.32 Million USD | -767.071% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4451.636% |
| Shattuck Labs, Inc. | 4.2 Million USD | -10491.599% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -122844.475% |
| Design Therapeutics, Inc. | 3.05 Million USD | -14492.098% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -169769.847% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -3028.05% |
| Achilles Therapeutics plc | 4.61 Million USD | -9543.749% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -19.089% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1378.65% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -11935.563% |
| Beam Therapeutics Inc. | 173.17 Million USD | -157.003% |
| Moolec Science SA | 2.64 Million USD | -16724.589% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -93596.632% |
| AEON Biopharma, Inc. | 278 Thousand USD | -159993.165% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -6236.261% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -132753.433% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -486.669% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -628.327% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1373.254% |
| Athira Pharma, Inc. | 1.58 Million USD | -27979.432% |
| HCW Biologics Inc. | 6.45 Million USD | -6798.239% |
| XOMA Corporation | 124.45 Million USD | -257.621% |
| NeurAxis, Inc. | 224.26 Thousand USD | -198356.702% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6658.679% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4451.636% |
| 180 Life Sciences Corp. | 1.32 Million USD | -33614.829% |
| Nektar Therapeutics | 230.4 Million USD | -93.167% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2134.12% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2505.713% |
| Arvinas, Inc. | 3.4 Million USD | -12989.971% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -28521.158% |
| Palisade Bio, Inc. | 369 Thousand USD | -120512.195% |
| Nutriband Inc. | 241.28 Thousand USD | -184353.654% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -27175.368% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -53781.235% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -107143.133% |
| Merus N.V. | 12.16 Million USD | -3559.423% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -246.544% |
| Neurogene Inc. | 16.25 Million USD | -2637.982% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -44.433% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1459.367% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -3121.797% |
| Rezolute, Inc. | 2.22 Million USD | -19875.718% |
| Clene Inc. | 32.16 Million USD | -1283.847% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -254142.429% |
| BeyondSpring Inc. | 3.99 Million USD | -11040.401% |
| Synlogic, Inc. | 17.27 Million USD | -2476.318% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -34135.308% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1271497.143% |
| Peak Bio, Inc. | 10.72 Million USD | -4050.97% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -757.152% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5398.629% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -151.423% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -6206.632% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -325726.171% |
| MannKind Corporation | 382.37 Million USD | -16.392% |
| Ikena Oncology, Inc. | 10.73 Million USD | -4044.71% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -108716.381% |
| Gossamer Bio, Inc. | 212.46 Million USD | -109.475% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -255681.034% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4758.192% |
| Legend Biotech Corporation | 328.67 Million USD | -35.411% |
| Mural Oncology plc | 15 Million USD | -2865.281% |
| Disc Medicine, Inc. | 2.1 Million USD | -21083.198% |
| Champions Oncology, Inc. | 7.43 Million USD | -5890.027% |
| REGENXBIO Inc. | 89.29 Million USD | -398.442% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -51972.138% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -80383.452% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -8120.521% |
| Vaxart, Inc. | 26.51 Million USD | -1578.581% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2742.491% |
| Cellectis S.A. | 92.85 Million USD | -379.316% |
| Longeveron Inc. | 2.04 Million USD | -21705.928% |
| Repare Therapeutics Inc. | 3.41 Million USD | -12951.584% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 68.137% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -855.226% |
| Revolution Medicines, Inc. | 87.94 Million USD | -406.071% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -257159.538% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -11158.765% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -140297.161% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -254219.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 44.946% |
| Denali Therapeutics Inc. | 52.24 Million USD | -751.934% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2989.515% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -32291.485% |
| Cingulate Inc. | 3.13 Million USD | -14096.011% |
| Passage Bio, Inc. | 26.29 Million USD | -1592.626% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -6577.554% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -108983.088% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -49682.886% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2064.579% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -18057.366% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -14151.009% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -54777.805% |
| OmniAb, Inc. | 25.56 Million USD | -1641.164% |
| Anew Medical, Inc. | 1.6 Million USD | -27629.533% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1404.449% |
| Lipocine Inc. | 17.16 Thousand USD | -2592577.386% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3724.188% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1185.258% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7434.358% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -678.443% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -219140.887% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -8516.825% |
| Ocugen, Inc. | 6.94 Million USD | -6312.03% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3049.968% |
| Q32 Bio Inc. | 1.31 Million USD | -33667.754% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -66129.018% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1266.05% |
| Equillium, Inc. | 824 Thousand USD | -53912.015% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4802.071% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -147855.493% |
| Dominari Holdings Inc. | 3.02 Million USD | -14598.118% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -470926.702% |
| vTv Therapeutics Inc. | 529 Thousand USD | -84032.136% |
| Bio-Techne Corporation | 419.53 Million USD | -6.083% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -518.172% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -129.926% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2535.356% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1855.272% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -7246.633% |
| Nkarta, Inc. | 88.33 Million USD | -403.808% |
| BioCardia, Inc. | 1.31 Million USD | -33744.791% |
| Iterum Therapeutics plc | 19.5 Million USD | -2181.301% |